Biomarin Pharmaceutical (bmrn 0.599 08/01/24)
13F holders, Q1 2024 (March 31)14holders
$1.52avg. 13F price*
At the end of Q1 2024, 14 institutions reported holding Biomarin Pharmaceutical (bmrn 0.599 08/01/24) in their 13F filings. The largest holders were Lord, Abbett & Co. LLC ($42.4M), Loomis Sayles & Co. L P ($40.9M) and Thrivent Financial for Lutherans ($10.0M).
- Company
- Biomarin Pharmaceutical (bmrn 0.599 08/01/24)
- CUSIP
- 09061GAH4
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $7.5M |
| Exits | 2 | $2.2M |
Ownership 14 holders
| Lord, Abbett & Co. LLC | 0.14% | Add +259.3% | 43,121,000 | $42.4M |
| Loomis Sayles & Co. L P | 0.06% | Reduce -18.1% | 468,775 | $40.9M |
| Thrivent Financial for Lutherans | 0.02% | No change | 10,150,000 | $10.0M |
| Opti Capital Management, LP | 0.57% | New | 7,600,000 | $7.5M |
| Sonora Investment Management Group, LLC | 0.47% | Reduce -1.8% | 6,085,000 | $6.0M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 3,500,000 | $3.4M |
| Jane Street Group, LLC | 0.00% | Reduce -3.7% | 2,575,000 | $2.5M |
| Truist Financial Corp. | 0.00% | Reduce -8.9% | 1,954,000 | $1.9M |
| Oppenheimer Asset Management Inc. | 0.00% | Reduce -49.5% | 151,000 | $148K |
| Stephens Inc. | 0.00% | Add +51.1% | 139,000 | $136K |
| Stonegate Investment Group, LLC | 0.00% | Add +284.6% | 50,000 | $49K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 32,000 | $31K |
| Prudent Investors Network, Inc. | 0.00% | — | 12,000 | $12K |
| Fox Hill Wealth Management | 0.01% | New | 11,000 | $11K |
"% of holder's portfolio" is BIOMARIN PHARMACEUTICAL (BMRN 0.599 08/01/24)'s weight in each manager's 13F, not the share of Biomarin Pharmaceutical (bmrn 0.599 08/01/24) the manager owns.